year 17, Issue 66 (5-2018)
J. Med. Plants 2018, 17(66): 156-166 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bahmani F, Esmaeili S, Gharehbaghian A, Gharehbaghian A. Cytotoxicity of Three Species of Centaurea Genus on Acute Lymphoblastic Leukemia Cell Line (Nalm-6). J. Med. Plants. 2018; 17 (66) :156-166
URL: http://jmp.ir/article-1-2180-en.html
URL: http://jmp.ir/article-1-2180-en.html
1- 1- Department of Hematology and Blood Banking, School of Allied Medicine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- 2- Traditional Medicine and Materia Medica Research Center (TMRC), School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- 3- Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- 2- Traditional Medicine and Materia Medica Research Center (TMRC), School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- 3- Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract: (2053 Views)
Background: Medicinal plants are considered as one of the ideal therapeutic sources for cancer prevention or treatment due to their bioactive contents and low side effects to humans. Centaurea genus have shown potential anti-tumor activity on some cancer cell lines in previous studies.
Objective: The aim of this study was to evaluate the cytotoxic effect of three species of Centaurea genus (C. albonitens, C. pseudoscabiosa, C. salicifolia) on Nalm-6 cells.
Methods: Nalm-6 cells were treated with increasing concentrations of the methanolic extracts of the aerial parts of three Centaurea species, then, their cytotoxic and anti-proliferative effects were evaluated using trypan blue, MTT and DAPI staining assays. Moreover, annexin V/PI staining and cell cycle analysis were performed for further investigation.
Results: The results of trypan blue, MTT assay and DAPI staining revealed that all 3 extracts exhibit cytotoxic and anti-proliferative properties against Nalm-6 cells in a dose- and time-dependent manner (P≤0.001). Interestingly, there was no considerable cytotoxicity in normal cells, MDBK. The flow cytometric analysis validated that Centaurea dose dependently induces apoptosis and G1 phase arrest in Nalm-6 cells (P≤0.01).
Conclusion: Due to the safety profile of the natural products, our study suggests that Centaurea extracts might provide insight into a novel therapeutic strategy and may confer advantages for acute lymphoblastic leukemia treatment, however further researches are necessary.
Objective: The aim of this study was to evaluate the cytotoxic effect of three species of Centaurea genus (C. albonitens, C. pseudoscabiosa, C. salicifolia) on Nalm-6 cells.
Methods: Nalm-6 cells were treated with increasing concentrations of the methanolic extracts of the aerial parts of three Centaurea species, then, their cytotoxic and anti-proliferative effects were evaluated using trypan blue, MTT and DAPI staining assays. Moreover, annexin V/PI staining and cell cycle analysis were performed for further investigation.
Results: The results of trypan blue, MTT assay and DAPI staining revealed that all 3 extracts exhibit cytotoxic and anti-proliferative properties against Nalm-6 cells in a dose- and time-dependent manner (P≤0.001). Interestingly, there was no considerable cytotoxicity in normal cells, MDBK. The flow cytometric analysis validated that Centaurea dose dependently induces apoptosis and G1 phase arrest in Nalm-6 cells (P≤0.01).
Conclusion: Due to the safety profile of the natural products, our study suggests that Centaurea extracts might provide insight into a novel therapeutic strategy and may confer advantages for acute lymphoblastic leukemia treatment, however further researches are necessary.
Type of Study: Research |
Subject:
Pharmacognosy & Pharmaceutics
Received: 2017/07/31 | Accepted: 2017/10/9 | Published: 2018/06/24
Received: 2017/07/31 | Accepted: 2017/10/9 | Published: 2018/06/24
Send email to the article author
